LAVA THERAPEUTICS
Lava Therapeutics, B.V.
Application Filed: 2021-09-24
Trademark Application Details
NEW APPLICATION - ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79354142 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | L60 |
| Employee Name | PATEL, SAMIR RAMESH |
Timeline
| 2021-09-24 | Application Filed |
| 2022-11-04 | Location: TMEG LAW OFFICE 106 |
| 2022-11-04 | Status: Live/Pending |
| 2022-11-04 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Lava Therapeutics, B.V. |
| Address | Yalelaan 60 NL-3584 CM Utrecht XP |
| Legal Entity Type | |
| Legal Entity State | XP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for T-Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders |
| GS0051 | Pharmaceutical preparations for T-Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations for the treatment of cancer autoimmune diseases, and immunological disorders; chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-11-03 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-11-04 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2022-11-04 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2022-11-08 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2022-11-12 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-11-13 | 6 RFCR E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-01-11 | 7 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-01-11 | 8 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-01-11 | 9 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-01-11 | 10 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-01-11 | 11 CHAN I:Incoming Correspondence |
| REFUSAL PROCESSED BY MPU | 2023-01-20 | 12 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-01-20 | 13 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-02-15 | 14 RFNT P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2023-03-17 | 15 NREP P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2023-04-03 | 16 ADCH M: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-04-03 | 17 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-04-03 | 18 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-04-03 | 19 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-08-07 | 20 CNSA O:Outgoing Correspondence |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2023-08-22 | 21 PBCR Z:Deletion |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-09-06 | 22 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-09-06 | 23 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-09-06 | 24 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2023-09-25 | 25 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2023-09-26 | 26 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-09-26 | 27 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2023-12-12 | 28 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-12-12 | 29 NRCC E:E-Mail |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-03-12 | 30 FICR P: |
| FINAL DISPOSITION PROCESSED | 2024-03-14 | 31 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2024-03-14 | 32 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2024-04-08 | 33 FINO P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LAVA THERAPEUTICS 87606681 5578442 Live/Registered |
Lava Therapeutics B.V. 2017-09-13 |
 LAVA THERAPEUTICS 79354142 not registered Live/Pending |
Lava Therapeutics, B.V. 2021-09-24 |
 LAVA THERAPEUTICS 79328096 not registered Live/Pending |
Lava Therapeutics, B.V. 2021-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 